FDA Inspection 1314462 — Transhumance Holding Company, Inc.
The FDA completed an inspection of Transhumance Holding Company, Inc. on April 15, 2026 in Dixon, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 15, 2026
- Fiscal Year
- 2026
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- Dixon, CA (United States)